Dianne Sako
Acceleron Pharma (United States)(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Cell Adhesion Molecules Research, TGF-β signaling in diseases, Lymphoma Diagnosis and Treatment, Pulmonary Hypertension Research and Treatments
Most-Cited Works
- → Expression cloning of a functional glycoprotein ligand for P-selectin(1993)725 cited
- → A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding(1995)439 cited
- → Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis(2014)425 cited
- → Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy(1986)319 cited
- → Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth(2011)221 cited
- → ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension(2020)210 cited
- Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens.(1985)
- → Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex(2012)174 cited
- → P-selectin Glycoprotein Ligand-1 Is the Major Counter-receptor for P-selectin on Stimulated T Cells and Is Widely Distributed in Non-functional Form on Many Lymphocytic Cells(1995)159 cited
- → P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities.(1992)159 cited